Alembic receives EIR for oncology injectable formulation facility at Panelav
This was a pre-approval inspection to cover our Oncology Injectable drug products for which ANDAs were filed with USFDA
This was a pre-approval inspection to cover our Oncology Injectable drug products for which ANDAs were filed with USFDA
Expanded capacity in Nansha, China will support mid-scale manufacturing to ensure a smooth transition between early-phase and large-scale commercial production
Gland Pharma enters into a Put Option Agreement to acquire 100% of Cenexi Group
Approval broadens indication for ENHERTU to earlier use in metastatic breast cancer and requirement for confirmatory phase 3 trial
Total investment envisaged in this project stands at up to Rs 70 crore
ASG is accelerating its doctor-led mission to enhance the quality of care, deliver eye care for all, and improve quality of life across India.
The Group will continue to make proactive investments of its management resources in the life science business
Pantoprazole Sodium Sesquihydrate are proton pump inhibitors used in drugs to suppress the gastric acid secretion
The expansion program includes investments in France and the U.S., adding an additional 23,000+ m² of manufacturing footprint.
None of the observations are related to data integrity and Alembic Pharmaceuticals management believes that they are addressable
Subscribe To Our Newsletter & Stay Updated